Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Aptamer-assisted superparamagnetic iron oxide nanoparticles as multifunctional drug delivery platform for chemo-photodynamic combination therapy.

Sun X, Liu B, Chen X, Lin H, Peng Y, Li Y, Zheng H, Xu Y, Ou X, Yan S, Wu Z, Deng S, Zhang L, Zhao P.

J Mater Sci Mater Med. 2019 Jun 19;30(7):76. doi: 10.1007/s10856-019-6278-y.

PMID:
31218573
2.

Thermally cross-linked superparamagnetic iron oxide nanoparticle-A10 RNA aptamer-doxorubicin conjugate.

Zhang H.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2008 Aug 29 [updated 2008 Oct 8].

3.

Multifunctional AS1411-functionalized fluorescent gold nanoparticles for targeted cancer cell imaging and efficient photodynamic therapy.

Ai J, Xu Y, Lou B, Li D, Wang E.

Talanta. 2014 Jan;118:54-60. doi: 10.1016/j.talanta.2013.09.062. Epub 2013 Oct 9.

PMID:
24274270
4.

In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.

Mosafer J, Abnous K, Tafaghodi M, Mokhtarzadeh A, Ramezani M.

Eur J Pharm Biopharm. 2017 Apr;113:60-74. doi: 10.1016/j.ejpb.2016.12.009. Epub 2016 Dec 21.

PMID:
28012991
5.

Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.

Mosafer J, Teymouri M, Abnous K, Tafaghodi M, Ramezani M.

Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:123-133. doi: 10.1016/j.msec.2016.11.053. Epub 2016 Nov 16.

PMID:
28024568
6.

AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.

Alibolandi M, Ramezani M, Abnous K, Hadizadeh F.

J Pharm Sci. 2016 May;105(5):1741-1750. doi: 10.1016/j.xphs.2016.02.021. Epub 2016 Mar 30.

PMID:
27039356
7.

Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.

Jalalian SH, Taghdisi SM, Shahidi Hamedani N, Kalat SA, Lavaee P, Zandkarimi M, Ghows N, Jaafari MR, Naghibi S, Danesh NM, Ramezani M, Abnous K.

Eur J Pharm Sci. 2013 Oct 9;50(2):191-7. doi: 10.1016/j.ejps.2013.06.015. Epub 2013 Jul 5.

PMID:
23835028
8.

Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer.

Siminzar P, Omidi Y, Golchin A, Aghanejad A, Barar J.

J Drug Target. 2019 Jun 27:1-10. doi: 10.1080/1061186X.2019.1616745. [Epub ahead of print]

PMID:
31062625
9.

Enhanced Anti-tumor of Pep-1 Modified Superparamagnetic Iron Oxide/PTX Loaded Polymer Nanoparticles.

Wang B, Wu W, Lu H, Wang Z, Xin H.

Front Pharmacol. 2019 Jan 22;9:1556. doi: 10.3389/fphar.2018.01556. eCollection 2018.

10.

Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles.

Yu MK, Kim D, Lee IH, So JS, Jeong YY, Jon S.

Small. 2011 Aug 8;7(15):2241-9. doi: 10.1002/smll.201100472. Epub 2011 Jun 7.

PMID:
21648076
11.

Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.

Yu MK, Park J, Jeong YY, Moon WK, Jon S.

Nanotechnology. 2010 Oct 15;21(41):415102. doi: 10.1088/0957-4484/21/41/415102. Epub 2010 Sep 17.

PMID:
20852354
12.

Aptamer-based tumor-targeted drug delivery for photodynamic therapy.

Shieh YA, Yang SJ, Wei MF, Shieh MJ.

ACS Nano. 2010 Mar 23;4(3):1433-42. doi: 10.1021/nn901374b.

PMID:
20166743
13.

Core/Shell Structured Fe₃O₄@TiO₂-DNM Nanospheres as Multifunctional Anticancer Platform: Chemotherapy and Photodynamic Therapy Research.

Liu MC, Liu B, Sun XY, Lin HC, Lu JZ, Jin SF, Yan SQ, Li YY, Zhao P.

J Nanosci Nanotechnol. 2018 Jul 1;18(7):4445-4456. doi: 10.1166/jnn.2018.15338.

PMID:
29442618
14.

Epirubicin-loaded superparamagnetic iron-oxide nanoparticles for transdermal delivery: cancer therapy by circumventing the skin barrier.

Rao YF, Chen W, Liang XG, Huang YZ, Miao J, Liu L, Lou Y, Zhang XG, Wang B, Tang RK, Chen Z, Lu XY.

Small. 2015 Jan 14;11(2):239-47. doi: 10.1002/smll.201400775. Epub 2014 Jun 13.

PMID:
24925046
15.

A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.

Baneshi M, Dadfarnia S, Shabani AMH, Sabbagh SK, Haghgoo S, Bardania H.

Int J Pharm. 2019 Jun 10;564:145-152. doi: 10.1016/j.ijpharm.2019.04.025. Epub 2019 Apr 9.

PMID:
30978484
16.

Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.

Liu J, Wei T, Zhao J, Huang Y, Deng H, Kumar A, Wang C, Liang Z, Ma X, Liang XJ.

Biomaterials. 2016 Jun;91:44-56. doi: 10.1016/j.biomaterials.2016.03.013. Epub 2016 Mar 10.

PMID:
26994877
17.

Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery.

Wu J, Song C, Jiang C, Shen X, Qiao Q, Hu Y.

Mol Pharm. 2013 Oct 7;10(10):3555-63. doi: 10.1021/mp300686g. Epub 2013 Aug 28.

PMID:
23679916
18.

Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.

Alibolandi M, Taghdisi SM, Ramezani P, Hosseini Shamili F, Farzad SA, Abnous K, Ramezani M.

Int J Pharm. 2017 Mar 15;519(1-2):352-364. doi: 10.1016/j.ijpharm.2017.01.044. Epub 2017 Jan 23.

PMID:
28126548
19.

Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.

Feng Q, Zhang Y, Zhang W, Hao Y, Wang Y, Zhang H, Hou L, Zhang Z.

Acta Biomater. 2017 Feb;49:402-413. doi: 10.1016/j.actbio.2016.11.035. Epub 2016 Nov 24.

PMID:
27890732
20.

Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells.

Aghanejad A, Babamiri H, Adibkia K, Barar J, Omidi Y.

Bioimpacts. 2018;8(2):117-127. doi: 10.15171/bi.2018.14. Epub 2018 May 5.

Supplemental Content

Support Center